本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

7.74
+0.31004.17%
成交量:6.28萬
成交額:49.05萬
市值:4,789.36萬
市盈率:-3.16
高:7.99
開:7.59
低:7.55
收:7.43
52周最高:13.69
52周最低:3.76
股本:618.78萬
流通股本:300.20萬
量比:1.34
換手率:2.09%
股息:- -
股息率:- -
每股收益(TTM):-2.4500
每股收益(LYR):-2.4500
淨資產收益率:-196.92%
總資產收益率:-69.33%
市淨率:0.89
市盈率(LYR):-3.16

資料載入中...

2024/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2023/11/23

SEC問詢函

Form CORRESP - Correspondence
2023/11/23

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/06

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]